Mambisa
Cuba’s journey of developing vaccines while battling US blockade

Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.

Cuba’s Abdala and Soberana 02 vaccines near the finish line

The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses

Cuba’s COVID-19 vaccines: A journey of collaboration and revolutionary solidarity

With its development of five COVID-19 vaccines and the promise of sharing know-how with developing countries, Cuba has remained faithful to Che Guevara’s values of international solidarity and people-oriented medicine

    × To Subscribe